Boltz

AI models for molecular discovery and development.

Sector

Life Sciences

Category

AI

Status

Private

Location

London, UK

Initial Investment

2026
AI models for molecular discovery and development.

Boltz is building frontier AI models and infrastructure to help scientists develop better molecules faster and with fewer physical experiments. Founded by researchers at MIT and building on the success of its widely adopted open-source models, the company has built a platform for protein and small-molecule design. Its technology is used by some of the world’s leading pharmaceutical, biotechnology, and materials science companies, helping accelerate breakthroughs in new therapeutics and advanced materials.